Emergence and global spread of epidemic healthcare-associated Clostridium difficile-Reference-Cited by-同舟云学术

Emergence and global spread of epidemic healthcare-associated Clostridium difficile

Published:2012-12-09 Issue:1 Volume:45 Page:109-113
ISSN:1061-4036
Container-title:Nature Genetics
language:en
Short-container-title:Nat Genet

Author:

He Miao,Miyajima Fabio,Roberts Paul,Ellison Louise,Pickard Derek J,Martin Melissa J,Connor Thomas R,Harris Simon R,Fairley Derek,Bamford Kathleen B,D'Arc Stephanie,Brazier Jon,Brown Derek,Coia John E,Douce Gill,Gerding Dale,Kim Hee Jung,Koh Tse Hsien,Kato Haru,Senoh Mitsutoshi,Louie Tom,Michell Stephen,Butt Emma,Peacock Sharon J,Brown Nick M,Riley Tom,Songer Glen,Wilcox Mark,Pirmohamed Munir,Kuijper Ed,Hawkey Peter,Wren Brendan W,Dougan Gordon,Parkhill Julian,Lawley Trevor D

Publisher

Springer Science and Business Media LLC

Subject

Genetics

Link

http://www.nature.com/articles/ng.2478.pdf

Reference45 articles.

1. Bartlett, J.G. Clostridium difficile: progress and challenges. Ann. NY Acad. Sci. 1213, 62–69 (2010).

2. Kelly, C.P. & LaMont, J.T. Clostridium difficile—more difficult than ever. N. Engl. J. Med. 359, 1932–1940 (2008).

3. Kuijper, E.J., Coignard, B. & Tull, P. Emergence of Clostridium difficile–associated disease in North America and Europe. Clin. Microbiol. Infect. 12 (suppl. 6), 2–18 (2006).

4. Warny, M. et al. Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe. Lancet 366, 1079–1084 (2005).

5. Riggs, M.M. et al. Asymptomatic carriers are a potential source for transmission of epidemic and nonepidemic Clostridium difficile strains among long-term care facility residents. Clin. Infect. Dis. 45, 992–998 (2007).

Cited by 619 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Virulence factors, antibiotic susceptibility and sequence type distribution of hospital-associated Clostridioides difficile isolates in Israel, 2020–2022;Scientific Reports;2024-09-04

2. Antimicrobial susceptibilities, resistance mechanisms and molecular characteristics of toxigenic Clostridioides difficile isolates in a large teaching hospital in Chongqing, China;Journal of Global Antimicrobial Resistance;2024-09

3. Blocking Toxin Function and Modulating the Gut Microbiota: Caffeic Acid and its Derivatives as Potential Treatments forClostridioides difficileInfection;2024-08-20

4. Epidemiology of Clostridioides difficile infection at one hospital 10 years after an outbreak of the epidemic C. difficile strain BI/027: changing strain prevalence, antimicrobial susceptibilities, and patient antibiotic exposures;Antimicrobial Agents and Chemotherapy;2024-08-07

5. Incidence of public health surveillance-reported Clostridioides difficile infections in thirteen countries worldwide: A narrative review;Anaerobe;2024-08